The development of predictive innate immunity assays for evaluating the effects of NP will allow questions about the immunological risk posed to living organisms (including human beings) to be answered in a realistic fashion, or addressed properly for the first time, a capability with significant attraction to prospective employers in academia. The exposure of fellows to different disciplines (from nanotechnology to evolution of immune responses to human immunity to safety/toxicology) and the intense exchange programme will allow them to expand the range of their scientific and technical knowledge and to learn how to work in multidisciplinary collaborations. Likewise, the industrial interest of the participating SMEs in the field of nanosafety assessment and screening will provide the fellows with a technical capability that is both specialised and marketable and, with their additional experience of working at the interface between academia and industry, should enhance their career prospects in both sectors. Moreover, the transferable skill courses foreseen in PANDORA will provide the ESRs with the necessary tools to become project managers, to find funds and to communicate effectively to different stakeholders or non-scientific media. The courses will guarantee that all ESRs will receive enough knowledge on various complementary topics to foster their entrepreneurial mind-set. The intersectoriality and interdisciplinary aspects of the partnership will create a generation of scientists able to adapt to changes in global technology and that will represent an investment into the research livelihood of the European Union.
Back to home